肿瘤免疫治疗肠道菌群数据

肠道菌群影响肿瘤免疫治疗效果。本产品整合了接受免疫治疗的泛癌肿患者的肠道菌群数据，涵盖了微生物种类的相对丰度、生物多样性及细菌组成等多维度信息。本产品旨在为科研人员和临床医生提供数据支持，助力发现新的生物标志物，优化治疗策略，推动肿瘤个体化医疗的创新性发展，从而提高肿瘤患者的预后。

Gut microbiota influences the efficacy of cancer immunotherapy. This product integrates gut microbiota data from pan-cancer patients who received immunotherapy, covering multi-dimensional information including relative abundance of microbial species, microbial biodiversity, and bacterial composition. It aims to provide data support for researchers and clinicians, facilitating the discovery of novel biomarkers, optimizing treatment strategies, advancing the innovative development of precision oncology, and ultimately improving the prognosis of cancer patients.

搜集汇总

背景与挑战

背景概述

该数据集整合了接受免疫治疗的泛癌肿患者的肠道菌群数据，包括微生物种类的相对丰度、生物多样性和细菌组成等多维度信息，旨在为科研人员和临床医生提供数据支持，助力发现新的生物标志物和优化治疗策略。数据集覆盖全国，更新频率为每年一次，存储大小为622 MB。